The Efficacy of intra-articular shoulder injection verses combined supra scapular and axillary nerve block for adhesive capsulitis: A double-blind Randomized Control Trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240901062926N1

Enrollment

Registered

2024-09-22

Start date

2024-09-05

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesive capsulitis AC or Frozen Shoulder. Adhesive capsulitis of unspecified shoulder

Interventions

Intervention 1: Intervention group: We will gather baseline measurements of shoulder discomfort, range of motion (ROM), and functional status in addition to demographic information and medical history

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Stage 2-3 AC unilateral No shoulder injuries in the previous three months• Absence of shoulder injections Absence of bleeding disorders no prior history of cancer• absence of inflammatory illness history Ages Eligible for Study: 30 Years to 70 Years (Adult, Older Adult) Sexes Eligible for Study: All

Exclusion criteria

Exclusion criteria: Malignancy Inflammatory disease

Design outcomes

Primary

Measure	Time frame
Shouder Pain And Disability, Range of Motion, Quailty of Life. Timepoint: 2, 4, 6, 8, 10, and 12 weeks. Method of measurement: for Shoulder Pain and Disability Index SPADI, for pain assessment VAS, for Range of Motion will be assess by Goniometer. assessing quality of life SF-36 will be used.	—

Secondary

Measure	Time frame
The secondary outcome of the study is assesment of quaility of life at different interval. Quaility of life will assess by SF-36 questionnaire. Timepoint: 2nd ,4th ,6th ,8th, and 12th weeks. Method of measurement: Quality of life SF-36 The SF-36 will be used to assess quality of life at baseline as well as three weeks, three months, and twelve months after the intervention. 36 items total, divided into eight domains by this widely used self-administered questionnaire: five for vitality, five for mental health, two for bodily pain, two for social function, ten for physical function, four for physical role, three for emotional role, and five for general health. A lower figure indicates a worse situation. From 0 to 100 is the range of scores.	—

Measure

Time frame

The secondary outcome of the study is assesment of quaility of life at different interval. Quaility of life will assess by SF-36 questionnaire. Timepoint: 2nd ,4th ,6th ,8th, and 12th weeks. Method of measurement: Quality of life SF-36 The SF-36 will be used to assess quality of life at baseline as well as three weeks, three months, and twelve months after the intervention. 36 items total, divided into eight domains by this widely used self-administered questionnaire: five for vitality, five for mental health, two for bodily pain, two for social function, ten for physical function, four for physical role, three for emotional role, and five for general health. A lower figure indicates a worse situation. From 0 to 100 is the range of scores.

—

Countries

Pakistan

Contacts

Public ContactDr Waqas

Ghurki Trust Teaching Hospital

tayyabm851@gmail.com+92 307 8625941

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026